Goater Jeff
Director at Surface Oncology, Inc.
- Sold, on record
- $2.8M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Jul 21, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Surface Oncology, Inc.Director
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Surface Oncology, Inc.Plan not statedJan 19, 2021 2021
Sold 5,000 shares at $13.00 ($65k)
Goater Jeff, Chief Executive Officer
Sold 1.9% of holdings ($3.5M position)262,000 shares leftFirst sale on recordFiling
- 2 Form 4 sale Surface Oncology, Inc.Plan not statedFeb 1, 2021 +13 days
Sold 2,500 shares at $10.69 ($27k)
Goater Jeff, Chief Executive Officer
Sold 0.9% of holdings ($2.8M position)262,000 shares leftFiling
- 3 Form 4 sale Surface Oncology, Inc.Plan not statedFeb 8, 2021 +7 days
Sold 2,500 shares at $12.50 ($31k)
Goater Jeff, Chief Executive Officer
Sold 0.9% of holdings ($3.3M position)262,000 shares leftFiling
- 4 Form 4 sale Surface Oncology, Inc.UnusualJun 11, 2021 +123 days
Sold 250,000 shares at $7.66 ($1.9M)
Goater Jeff, Director
Sold 49.3% of holdings ($3.9M position)257,000 shares left100x usual sizeFiling
- 5 Form 4 sale Surface Oncology, Inc.UnusualJul 21, 2021 +40 days
Sold 127,778 shares at $6.10 ($779k)
Goater Jeff, Director
Sold 49.7% of holdings ($1.6M position)129,222 shares left34.1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 21, 2021 | Jan 14, 2022 | Surface Oncology, Inc. | Director | Form 4 sale | 127,778 | $779k | 49.7% | Unusual | SEC |
| Jun 11, 2021 | Jun 11, 2021 | Surface Oncology, Inc. | Director | Form 4 sale | 250,000 | $1.9M | 49.3% | Unusual | SEC |
| Feb 8, 2021 | Feb 9, 2021 | Surface Oncology, Inc. | Chief Executive Officer | Form 4 sale | 2,500 | $31k | 0.9% | Plan not stated | SEC |
| Feb 1, 2021 | Feb 3, 2021 | Surface Oncology, Inc. | Chief Executive Officer | Form 4 sale | 2,500 | $27k | 0.9% | Plan not stated | SEC |
| Jan 19, 2021 | Jan 21, 2021 | Surface Oncology, Inc. | Chief Executive Officer | Form 4 sale | 5,000 | $65k | 1.9% | Plan not stated | SEC |